Why the study?
Does continuous ICV administration of SQ14225 reduce blood pressure in DOCA-salt hypertensive rats?
Population
DOCA (deoxycorticosterone acetate)-salt hypertensive rats
Design
Preclinical
Follow-up
7 days
Authors
Loading...
Central RAS blockade may attenuate salt-sensitive hypertension in rats; hypothesis-generating with no implications for clinical practice.
Does continuous ICV administration of SQ14225 reduce blood pressure in DOCA-salt hypertensive rats?
Blockade of the brain renin-angiotensin system with ICV SQ14225 attenuates blood pressure increases in DOCA-salt hypertensive rats, mediated by changes in fluid intake, vasopressin, and baroreceptor reflexes.
Itaya et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: